Skip to main navigation
Skip to search
Skip to main content
The University of Brighton Home
Search content at The University of Brighton
Home
Profiles
Research units
Equipment
Projects
Research output
Activities
Student theses
Hypoxia as a target for drug combination therapy of liver cancer
Cressida Bowyer
, Andrew Lewis
,
Andrew Lloyd
, Gary Phillips
,
Wendy Macfarlane
University of Brighton
Centre for Regenerative Medicine and Devices
Centre for Lifelong Health
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Profiles
(2)
Fingerprint
Dive into the research topics of 'Hypoxia as a target for drug combination therapy of liver cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Hypoxia
100%
Doxorubicin
100%
Combination Therapy
100%
Liver Cancer
100%
Combination Drug
100%
Liver Cell Carcinoma
71%
Hypoxia Inducible Factor 1
57%
Rapamycin
42%
Malignant Neoplasm
28%
Western Blot
14%
Transcription Factors
14%
Pharmacotherapy
14%
Cancer Mortality
14%
Medicine and Dentistry
Liver Cancer
100%
Combination Drug Therapy
100%
Mammalian Target of Rapamycin
14%
Keyphrases
Lowest Effective Dose
16%
Doxorubicin Chemotherapy
16%
Ectopic Xenografts
16%
Xenograft Model
16%
Embolotherapy
16%